Karyopharm Therapeutics logo

Karyopharm Therapeutics

KPTI | NASDAQ
Chart Builder DCF Calculator
$0.11
-$0.55 (-83.38%)
At close: Nov 2, 2026, 4:00 PM ET
-83.38%

Rating

Updated: Nov 2, 2026
46.5
+1.0 pts
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #354/1028 (Top 34%)

Key Statistics

Market Data

Market Cap $2.54M
1D Range
0.09 0.28
52W Range
0.09 10.67

Valuation (TTM)

PE -0.01
PB -0.01
EV/EBITDA -0.87

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $7.33
Loading financial charts...

Profile

Karyopharm Therapeutics Inc. is a pharmaceutical company that has already brought products to market, focusing on identifying, advancing, and selling medications designed to disrupt nuclear export pat...

Sector Healthcare
Industry Biotechnology
Employees 228
IPO Date Nov 6, 2013
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
5
Consensus
Buy
Price Target
$3.00
Upside
+2627.27%
Buy (3)
Hold (2)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.